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Type 2 diabetes is associated with more
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Background. Data on coronary plaque observations on multi-slice computed tomography
(MSCT) in patients with type 2 diabetes are scarce.
Methods and Results. In total, 60 patients (19 with diabetes) underwent 64-slice MSCT,
followed by conventional coronary angiography with intravascular ultrasound (IVUS). Non-
invasively, the extent of coronary atherosclerosis and 3 plaque types (non-calcified, calcified,
mixed) were visually evaluated on MSCT. Invasively, plaque burden was assessed on gray-scale
IVUS. Plaque composition was evaluated on virtual histology intravascular ultrasound (VH
IVUS). Concerning geometrical plaque data, diabetic patients showed more plaques on MSCT
(7.1 ± 3.2 vs 4.9 ± 3.2 in non-diabetic patients, P = .01). On gray-scale IVUS, diabetes was
associated with a larger plaque burden (48.7 ± 10.7% vs 40.0 ± 12.1%, P = .003). Concerning
plaque composition, diabetes was associated with more calcified plaques on MSCT (52% vs
24%). Relatively more fibrocalcific plaques in diabetic patients (29% versus 9%) were observed
on VH IVUS. Moreover, these plaques contained more necrotic core (10.8 ± 5.9% vs
8.6 ± 5.2%, P = .01).
Conclusion. A higher plaque extent and more calcified lesions were observed in diabetic
patients on MSCT. The findings were confirmed on gray-scale and VH IVUS. Thus, MSCT may
potentially be used to explore patterns of coronary atherosclerosis in diabetic patients. (J Nucl
Cardiol 2009;16:376–83.)
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Type 2 diabetes is strongly associated with the
development of coronary artery disease (CAD).1 Thus
far, functional testing has been used to detect CAD in
diabetic patients, including myocardial perfusion scin-
tigraphy and stress echocardiography. Although
abnormal test results have been clearly associated with
the development of cardiovascular events on follow-up,
elevated event rates have also been observed in patients
without detectable ischemia.2,3 These findings suggest
that to some extent the increased cardiovascular risk in
patients with diabetes could be attributed to the presence
of diffuse CAD rather than focal high-grade lesions.
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Accordingly, direct visualization of coronary ath-
erosclerosis could be superior to detection of ischemia
for risk stratification of diabetic patients. Both non-
invasive and invasive modalities are currently available
and may be useful for this purpose. The available studies
thus far have mainly addressed the quantification of
plaque burden. Indeed, diabetes was demonstrated to be
a strong predictor of increased atherosclerotic volume on
gray-scale intravascular ultrasound (IVUS).4 Non-inva-
sively, increased calcific plaque burden was observed in
diabetic patients on electron beam computed tomogra-
phy.5 Nonetheless, although the above techniques allow
estimation of coronary plaque extent, they are subopti-
mal for the assessment of plaque composition.
Recently, multi-slice computed tomography
(MSCT) coronary angiography was introduced, which in
addition to visualization of obstructive and non-
obstructive plaques allows assessment of plaque com-
position.6,7 Invasively, plaque composition may be
evaluated by virtual histology IVUS (VH IVUS).8
However, only limited data are available on plaque
characterization by both techniques in diabetic patients.
Accordingly, the purpose of the study was to evaluate
coronary plaque extent and composition on MSCT and
to compare these findings with patterns of coronary
atherosclerosis on invasive angiography, gray-scale
IVUS, and VH IVUS. Patients with and without diabetes
were compared.
METHODS
Patients and Study Protocol
A total of 60 patients, 19 (32%) patients with type 2
diabetes and 41 (68%) patients without diabetes, were included
in the study. All patients presented with chest pain suggestive
of CAD. Diabetes was diagnosed according to the criteria as
set by the American Diabetes Association:9 (1) a fasting
plasma glucose level of C7.0 mmol/L or (2) symptoms of
diabetes and a casual plasma glucose level of C11.1 mmol/L.
The patients with a long history of diabetes and requiring
insulin and oral hypoglycemic agents were also diagnosed as
having diabetes. Patients underwent 64-slice MSCT coronary
angiography, followed within a month by conventional coro-
nary angiography in combination with IVUS of one to three
vessels. The clinical history of the patients was evaluated prior
to conventional coronary angiography to ensure that neither
acute coronary events nor worsening of angina occurred
between the examinations.
Patients were excluded from the study if contraindications
for MSCT were present.10 IVUS examination was not per-
formed if severe vessel tortuousness, severe luminal narrowing
precluding the insertion of the IVUS catheter or vessel
occlusion were present. Informed consent was obtained from
all patients.
MSCT
Image acquisition. MSCT coronary angiography
was performed using a 64-detector row Toshiba Aquilion
(Toshiba Medical Systems, Tokyo, Japan) scanner. A helical
scan protocol with electrocardiographic gating was applied as
described previously.11 Additional oral b-blockers (metopro-
lol, 50 or 100 mg, single dose, 1 hour prior to the examination)
were provided if the heart rate was C60 beats/minute and no
contraindications for the use of b-blockers were present. The
image dataset was initially reconstructed at the diastolic phase
of the R-R interval (75% of the R-R interval). In case of the
presence of motion artifacts additional phases were explored.
The middle segment of the right coronary artery was verified in
the end-systolic image reconstruction dataset in all patients
with good image quality at end-diastolic phase. Image recon-
structions obtained with either smooth or medium filters were
used for the evaluation of non-calcified plaques in all patients.
In the presence of extensive calcifications, reconstructions
obtained with a sharp filter were additionally analyzed to
verify calcium containing plaques.
Image analysis. Images were evaluated on a remote
workstation with dedicated software (Vitrea 2, Vital Images,
Minnetonka, Minnesota, USA and Advantage, GE Healthcare,
Boston, Massachusetts, USA). Two experienced observers
evaluated the examinations side-by-side in consensus. The
presence, extent and type of coronary plaques were assessed
using a qualitative visual approach as previously described.12
Briefly, the plaques were assessed using axial images and
curved multiplanar reconstructions. Plaques were defined as
structures [1 mm2 within and/or adjacent to the coronary
artery lumen, which could be clearly distinguished from the
vessel lumen and the surrounding tissue. Plaques were visually
classified as obstructive or not, using a threshold of 50%
luminal narrowing. Three types of plaques were distinguished:
non-calcified (composed only of low-density component),
mixed (composed of both low- and high-density components),
and calcified (composed only of high-density component).
Conventional Coronary Angiography
and Quantitative Coronary Angiography
Analysis
Conventional invasive coronary angiography was per-
formed according to standard protocols. An experienced
observer performed off-line quantitative coronary angiography
(QCA) analyses, using dedicated software (QCA CMS 6.0,
Medis Medical imaging systems, Leiden, The Netherlands).
For each vessel examined both with MSCT and IVUS, percent
luminal narrowing was reported at the site of the minimal
lumen area (MLA).
Gray-scale and VH IVUS
Image acquisition. IVUS examinations were per-
formed with a 20 MHz, 2.9 F phased-array IVUS catheter
(Eagle Eye, Volcano Corporation, Rancho Cordova,
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California, USA). After intracoronary administration of
nitrates, the catheter was introduced to the distal coronary
artery and withdrawn at a continuous speed of 0.5 mm/second
to the coronary ostium using automated pullback device (Track
Back, Volcano Corporation, Rancho Cordova, California,
USA). To define the starting position of the IVUS catheter,
cine runs before and during contrast injection were performed.
The images were stored for off-line analysis.
Image analysis. Gray-scale IVUS. To evaluate
geometrical plaque parameters, gray-scale IVUS datasets were
evaluated on a vessel level by an experienced observer, using
dedicated software (QCU CMS 4.0 Medis Medical imaging
systems, Leiden, The Netherlands). Cross-sectional images
spaced 0.5 mm apart in the pullback were analyzed within the
full length of the examined vessel. First, the contours of the
external elastic membrane (EEM) were identified and the mean
EEM area was calculated in the examined vessel. Subse-
quently, lumen-intima interface was identified and mean lumen
area was calculated. Plaque area was enclosed by the contours
of the EEM and the lumen-intima interface and mean plaque
area was identified per vessel. Plaque burden was calculated as
the percentage of the EEM occupied by plaque [Plaque burden
(%) = R(EEMarea - lumenarea)/REEMarea 9 100]. Percent of
abnormal images (having a maximal plaque thickness
[0.5 mm) was calculated in each examined vessel.13 Finally,
remodeling index was calculated by dividing the EEM area at
MLA site of the vessel by the EEM area at proximal reference
site. The latter was defined as the frame with largest lumen
area located within 10 mm from the MLA frame with no major
intervening side branches.14
Of note, the accuracy of the IVUS pullback device was
assessed by imaging single stents of known length (8-18 mm
stents) in a subpopulation of 15 patients (5 stents in the right
coronary artery, 5 stents in the left anterior descending coro-
nary artery, 5 stents in the left circumflex coronary artery). In
all included patients, the pullback was available at least 10 mm
beyond the distal end of the stent and at least 10 mm proximal
to the stent. The stents were measured between the distal and
proximal IVUS frames with complete circumferential appear-
ances of the stent struts.
VH IVUS. An experienced observer performed quantitative
VH IVUS image analysis on a plaque level using dedicated
software (pcVH 2.1, Volcano Corporation, Rancho Cordova,
California, USA). Qualitative VH IVUS analysis was performed
in consensus by two experienced observers. First, four tissues
were differentiated and labeled with different colors (fibrotic,
fibro-fatty tissues, necrotic core, and dense calcium), as
described and validated previously.8,15 The mean percentage of
each plaque component was obtained in the full length of each
plaque observed on MSCT. In addition, plaques were visually
assessed in three consecutive frames within 10 mm from the
MLA site of plaque and were classified into four different types
based on geometrical and compositional parameters as well as
the location of specific components in the plaque: (1) patho-
logical intimal thickening, (2) fibroatheroma, (3) thin cap
fibroatheroma, and (4) fibrocalcific plaque.16,17
Plaques were matched between MSCT and VH IVUS as
previously described.18 First, plaques were visually identified
on MSCT. The distances from the established landmarks
(coronary ostia, side-branches) to the starting point and the
termination point of the plaques were measured on multiplanar
reconstructions of the vessels on MSCT. These distances were
subsequently measured on the longitudinal mode of IVUS
datasets. The transversal IVUS sections were further inspected
and the starting and the termination frames of the lesions were
depicted.
Statistical Analysis
Categorical variables are expressed as numbers (per-
centages) and compared between groups with 2-tailed Chi-
square test. When normally distributed, continuous variables
are expressed as means (standard deviation) and compared
with the 2-tailed t-test for independent samples. When not
normally distributed, continuous variables are expressed as
medians (interquartile range) and compared with the 2-tailed
non-parametric Mann-Whitney test. To evaluate the repro-
ducibility of coronary plaque evaluation on MSCT and VH
IVUS Cohen’s kappa coefficient was calculated. The agree-
ment of QCA analysis was expressed as the difference of
percent diameter stenosis between the measurements.
P-values\.05 were considered as statistically significant.
Statistical analyses were performed using SPSS software
(version 14.0, SPSS Inc, Chicago, Ill, USA).
RESULTS
Baseline clinical characteristics of patients with
diabetes and without diabetes are provided in Table 1.
Geometrical Data of Coronary
Atherosclerosis (Plaque Extent)
MSCT. MSCT coronary angiograms were of
diagnostic quality in all patients. A good intra- and inter-
observer agreement was observed for the detection of
obstructive plaques (Cohen’s kappa coefficient 0.81 for
intra-observer variability and 0.81 for inter-observer
variability). The results of the geometrical analysis on
MSCT are presented in Table 2. The average number of
coronary plaques was higher in diabetic patients as
compared with patients without diabetes. In particular, a
trend for a higher number of non-obstructive plaques
was observed in diabetic patients (5.2 ± 2.7 in patients
with diabetes versus 3.8 ± 2.6 in patients without dia-
betes, P = .06).
QCA and gray-scale IVUS. A good intra- and
inter-observer agreement was observed for the evalua-
tion of stenosis severity on QCA (mean difference
7.4 ± 7.2% and 8.1 ± 7.4%, respectively). Similarly, a
good accuracy of the IVUS pullback device was
observed. The difference in known and measured stent
length was 1.7 ± 0.8 mm (P = .4), whereas the devia-
tion from known stent length was 10.9 ± 3.5%.
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Geometrical coronary plaque data obtained by QCA and
gray-scale IVUS are presented in Table 2. Briefly, on
gray-scale IVUS, more diffuse atherosclerosis was
observed in diabetic patients as reflected by a larger
plaque burden in the presence of diabetes. In addition,
the number of abnormal IVUS frames was also higher in
patients with diabetes. An example of diffuse athero-
sclerosis in a patient with type 2 diabetes on MSCT and
gray-scale IVUS is provided in Figure 1.
Compositional Data of Coronary
Atherosclerosis
MSCT. A good agreement was observed for the
classification of plaque type (Cohen’s kappa coefficient
0.85 for intra-observer variability and 0.74 for inter-
observer variability). As shown in Table 3, relatively
more calcified plaques were observed in diabetic patients
as compared with patients without diabetes. The propor-
tion of mixed plaques was similar between the two patient
populations, whereas non-calcified plaques were rela-
tively more prevalent in patients without diabetes.
VH IVUS. The results of coronary plaque compo-
sition on VH IVUS are presented in Table 3. Briefly, the
amount of dense calcium was larger in the plaques of
patients with diabetes as compared with patients without
diabetes. Moreover, the plaques of diabetic subjects
contained more necrotic core.
A good agreement was observed for the classifica-
tion of plaque type (Cohen’s kappa coefficient 0.75 for
intra-observer variability and 0.87 for inter-observer
variability). Qualitative assessment of lesions revealed a
higher prevalence of fibrocalcific plaques in diabetic
patients. In contrast, in patients without diabetes rela-
tively more lesions were classified as pathological
intimal thickening. No differences, however, were
observed in the prevalence of fibroatheroma and thin cap
fibroatheroma. An example of a mixed plaque on MSCT
and the corresponding plaque demonstrating features of
fibrocalcific plaque on VH IVUS is provided in
Figure 1.
DISCUSSION
The findings of coronary plaque characterization
using MSCT angiography, gray-scale, and VH IVUS
may be summarized as follows. First, the extent of
coronary plaques was higher in diabetic patients on
MSCT. This finding corresponded with more diffuse
atherosclerosis and a larger plaque burden on gray-scale
Table 1. Characteristics of patients with diabetes and without diabetes
Patients with
diabetes (n 5 19)
Patients without
diabetes (n 5 41) P value
Age (years) 60 ± 10 58 ± 11 .4
Male gender 14 (74%) 21 (51%) .1
BMI (kg/m2) 27.4 ± 3.6 26.3 ± 3.7 .3
HbA1c (%) 7.1 ± 1.4 – –
Risk factors
Hypercholesterolemia 18 (95%) 31 (76%) .08
Arterial hypertension 12 (63%) 24 (59%) .7
Smoking 9 (47%) 20 (49%) .9
Family history of CAD 5 (26%) 23 (56%) .03
Obesity 5 (26%) 8 (20%) .6
History of CAD
Previous MI/PCI 9 (47%) 12 (29%) .2
Medication
ACEI or ARB 12 (63%) 20 (49%) .3
Beta-blockers 9 (47%) 23 (56%) .5
Aspirin 14 (74%) 28 (68%) .7
Statins 18 (95%) 26 (63%) .01
Oral hypoglycemic agents 19 (100%) – –
Insulin 5 (26%) – –
Data are mean ± SD or n (%).
ACEI, Angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; BMI, body mass index; CAD, coronary artery
disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.
Journal of Nuclear Cardiology Pundziute et al 379
Volume 16, Number 3;376–83 Association of type 2 diabetes with more advanced coronary atherosclerosis
IVUS examination. Second, the proportion of com-
pletely calcified plaques on MSCT was larger in patients
with diabetes as compared with patients without diabe-
tes. On VH IVUS, this corresponded with a larger
amount of dense calcium and a higher prevalence of
fibrocalcific plaques. Finally, a larger amount of necrotic
core was observed in the plaques of diabetic patients,
whereas the prevalence of TCFA was identical between
the two patient populations.
Plaque Extent
In the present study, a higher extent of coronary
atherosclerosis was observed in diabetic patients both on
MSCT and on gray-scale IVUS. A trend toward a higher
number of non-obstructive plaques was observed
although the finding was not statistically significant.
This finding is in line with a previous study exploring
non-invasive coronary plaque characterization on MSCT
angiography.12 Indeed, in this study including 215
patients (86 patients with type 2 diabetes) diabetes was
associated with a higher prevalence of non-obstructive
coronary plaques.12 Moreover, the observation on
MSCT in the present study was paralleled by a more
diffuse atherosclerosis and a larger plaque burden on
gray-scale IVUS. Similar observations were reported by
Nicholls et al4 who reported on the measures of coronary
plaques on gray-scale IVUS in 654 patients, of which
128 had diabetes. The authors reported a significantly
larger plaque burden in diabetic patients. Increased
plaque extent on MSCT as well as on gray-scale IVUS
(namely due to non-obstructive and thus predominantly
non-flow limiting plaques) might explain a higher event
rate in diabetic population. Indeed, it has been observed
that plaques leading to myocardial infarction are most
often non-obstructive on invasive angiography months
prior to the occurrence of the event.19 Moreover, path-
ological studies of the victims of sudden cardiac death
have shown that the cross sectional area luminal nar-
rowing was below 75% (luminal narrowing of less than
50%) in more than 80% of plaques referred to as vul-
nerable to rupture.20 Nevertheless, it remains to be
Table 2. Geometrical data of coronary atherosclerosis on MSCT, gray-scale IVUS and QCA in patients
with diabetes and without diabetes
Diabetes present
(n 5 19 patients)
No diabetes
(n 5 41 patients) P value
MSCT n = 57 vessels
(134 plaques)
n = 123 vessels
(201 plaques)
Total Agatston calcium score 282 (54–578) 85 (3–326) .09
CAD present 19 (100%) 41 (100%) 1.0
Obstructive CAD 13 (68%) 22 (54%) .3
Non-obstructive CAD 6 (32%) 19 (46%) .3
Nr of vessels with any plaques 2.6 ± 0.7 2.2 ± 0.8 .08
Nr of vessels with obstructive plaques 1.3 ± 1.2 0.9 ± 1.1 .2
Nr of vessels with non-obstructive plaques 2.5 ± 0.8 2.0 ± 1.0 .08
Nr of any plaques 7.1 ± 3.2 4.9 ± 3.2 .02
Nr of obstructive plaques 1.9 ± 2.1 1.2 ± 1.7 .2
Nr of non-obstructive plaques 5.2 ± 2.7 3.8 ± 2.6 .06
Gray-scale IVUS and QCA n = 36 vessels n = 81 vessels
Examined vessel length (cm) 10.3 ± 8.7 8.3 ± 9.3 .4
Mean EEM area (mm2) 15.1 ± 4.6 14.1 ± 5.2 .4
Mean lumen area (mm2) 7.8 ± 2.8 8.2 ± 2.8 .5
Mean plaque area (mm2) 7.4 ± 3.1 5.9 ± 3.5 .07
Plaque burden (%) 48.7 ± 10.7 40.0 ± 12.1 .003
Percent abnormal frames in the
full length of the vessel (%)
90.4 ± 14.8 77.4 ± 27.1 .03
Lesion luminal narrowing on QCA (%) 33.8 ± 13.4 28.5 ± 17.5 .3
Remodeling index at the site of MLA 0.95 ± 0.07 0.97 ± 0.12 .4
Data are mean ± SD, median (interquatile range) or n (%).
CAD, Coronary artery disease; EEM, external elastic membrane; IVUS, intravascular ultrasound; MLA, minimal lumen area; MSCT,
multi-slice computed tomography; QCA, quantitative coronary angiography.
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determined in follow-up studies whether a higher plaque
extent as observed on MSCT may be able to predict the
increased cardiovascular event rate in diabetic patients.
A trend for a larger EEM area was observed in the
diabetic patients of the present study population.
Moreover, in accordance to the observations by Nicholls
et al,4 the degree of stenosis on QCA and the remodeling
index of the lesions of the present study did not differ
between the two patient populations, although more
plaque was observed in diabetic patients. The discrep-
ancy could be explained by the presence of diffuse
atherosclerosis also in the reference segment of plaques
of diabetic patients, as previously reported.21 As a
consequence, the QCA measurements as well as the
remodeling index may underestimate the actual plaque
burden. Moreover, previous studies showed that coro-
nary arteries of diabetic patients tend to undergo
negative remodeling.21,22 Nevertheless, no correlation
between vessel shrinkage and the presence of diabetes
was observed in the present study. Indeed, contrary to
previous studies the majority of coronary arteries that
were examined invasively in the present study contained
non-obstructive plaques. In addition, only a small pro-
portion of patients in the current study were insulin
dependent, whereas negative remodeling may be more
strongly related to insulin treatment than to non-insulin
dependent diabetes.22
Plaque Composition
In the present study, the proportion of completely
calcified plaques on MSCT was larger in patients with
diabetes as compared with patients without diabetes.
Similar observations on coronary calcifications were
reported in previous studies using electron beam com-
puted tomography and MSCT.5,12 Indeed, in a recent
MSCT study 49% of plaques were classified as com-
pletely calcified in diabetic patients.12 In contrast to the
above study, however, diabetic patients in the present
study contained a larger proportion of mixed plaques
and a smaller proportion of non-calcified plaques. This
finding could be explained by a higher risk profile of
patients as compared to the population of the previous
study. Accordingly, atherosclerosis could be more
advanced (with more extensive calcifications) in these
patients. As a consequence, the number of mixed pla-
ques was identical in diabetic patients and patients
without diabetes.
In accordance with the findings on MSCT, a larger
amount of dense calcium was observed in the plaques of
diabetic patients on VH IVUS. This observation is in
line with a pathological study by Burke et al23 who
demonstrated that type 2 diabetes was associated with a
larger area of calcified matrix. Similar findings were
recently reported by Nasu et al24 who investigated cor-
onary plaque composition on VH IVUS in the target
vessels of 36 type 2 diabetic patients and compared the
findings with patients without diabetes; the authors
reported a larger amount of dense calcium in the lesions
of diabetic patients. On visual evaluation, more plaques
of diabetic patients in the present study contained fea-
tures of fibrocalcific plaque. Indeed, based on
pathological investigations fibrocalcific plaque may
Figure 1. An example of coronary atherosclerosis in a patient
with type 2 diabetes as demonstrated by MSCT (A), gray-scale
IVUS (B), and VH IVUS (C). A, MSCT multiplanar recon-
struction of the right coronary artery, demonstrating diffuse
atherosclerosis along the course of the artery. A mixed plaque
is observed in the proximal part of the vessel both on
longitudinal and the transversal images. B, The presence of
diffuse atherosclerosis was confirmed on the longitudinally
reconstructed gray-scale IVUS image. C, The corresponding
image on VH IVUS at the site of MLA of the plaque, depicting
a lesion with the features of fibrocalcific plaque. IVUS,
Intravascular ultrasound; MSCT, multi-slice computed tomog-
raphy; MLA, minimal lumen area; VH IVUS, virtual histology
intravascular ultrasound.
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resemble the healing process following previous plaque
ruptures or erosions and accordingly represent advanced
atherosclerotic lesions.17
Finally and importantly, together with the presence
of extensive calcifications a larger amount of necrotic
core was observed in the plaques of diabetic patients on
VH IVUS. Indeed, increased amount of necrotic core
was shown to be a feature of increased risk to plaque
rupture.20 Nevertheless, the proportion of TCFA (the
precursor lesion of plaque rupture) was identical in
diabetic patients and in patients without diabetes. The
explanation of these findings may be twofold. First, the
patients of the study were extensively treated with car-
diovascular medication, which possibly could have
resulted in a more stabilized coronary plaque profile and
thus decreased development of TCFA. Second, the
coexistence of more extensive calcifications and the
absence of direct evidence of vulnerable plaque mor-
phology on VH IVUS may imply different
pathophysiological mechanisms of plaque instability in
diabetes.23 Further studies are necessary to better
understand the mechanisms that lead to plaque insta-
bility and cardiovascular events in diabetic patients.
LIMITATIONS
The findings of the study are based on a relatively
small patient population. Concerning MSCT, the tech-
nique is still associated with an elevated x-ray dose,
while also the administration of contrast material is
required. Also, no validated algorithms that allow
quantification of plaque stenosis, volume, and compo-
sition are available for MSCT at present. Thus, in the
present study MSCT studies were analyzed using a
qualitative visual approach without the use of dedicated
software algorithms or attenuation value measurements.
The limitation of VH IVUS is the fact that the technique
is relatively new, expensive and not widely available. As
a result, the current observations need confirmation in
future studies. In addition, both gray-scale IVUS and
VH IVUS are invasive techniques and accordingly
associated with risk. As a result their use remains
restricted to symptomatic patients. Importantly, these
investigations in larger patient cohorts should also
include follow-up, as data on the potential prognostic
value of both MSCT and VH IVUS are limited. Further
studies should address whether certain plaque charac-
teristics in diabetic patients may indeed be related to
adverse outcome.
CONCLUSIONS
In conclusion, differences in coronary plaque pat-
terns were observed on MSCT, gray-scale, and VH
IVUS between patients with versus without diabetes.
Diabetes was associated with a higher plaque extent as
determined both on MSCT and gray-scale IVUS. Con-
cerning plaque composition, more calcified plaques
Table 3. Compositional data of coronary plaques on MSCT and VH IVUS in patients with diabetes and
without diabetes
Diabetes present No diabetes P value
MSCT n = 134 plaques n = 201 plaques
Nr of calcified plaques 70 (52%) 49 (24%) \.001
Nr of mixed plaques 41 (31%) 82 (41%) .06
Nr of non-calcified plaques 23 (17%) 70 (35%) \.001
VH IVUS n = 59 plaques n = 110 plaques
Average percentage of plaque components
Fibrotic (%) 56.0 ± 7.6 57.7 ± 8.8 .2
Fibro-fatty (%) 26.8 ± 9.9 29.1 ± 11.8 .2
Necrotic core (%) 10.8 ± 5.9 8.6 ± 5.2 .01
Dense calcium (%) 6.4 ± 6.3 4.5 ± 4.3 .02
Plaque types
Fibrocalcific plaque 17 (29%) 10 (9%) .001
Fibroatheroma 28 (47%) 52 (47%) .98
Thin cap fibroatheroma 4 (7%) 11 (10%) .4
Pathological intimal thickening 10 (17%) 37 (34%) .02
Data are mean ± SD or n (%).
MSCT, Multi-slice computed tomography; VH IVUS, virtual histology intravascular ultrasound.
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were observed on MSCT in patients with diabetes. On
VH IVUS, plaques of diabetic patients contained a lar-
ger amount of dense calcium and were of a more
advanced stage based on visual qualification. Thus,
MSCT may potentially be used to explore patterns of
coronary atherosclerosis in diabetic patients.
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